Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · December 01, 2023

Effect of Lebrikizumab on Itch and Sleep Loss in Patients With Moderate to Severe Atopic Dermatitis

The British Journal of Dermatology


Additional Info

The British Journal of Dermatology
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials
Br J Dermatol 2023 Nov 06;[EPub Ahead of Print], G Yosipovitch, PA Lio, D Rosmarin, E Serra-Baldrich, FJ Legat, M Casillas, E Pierce, Z Liu, L Sun, H Elmaraghy, S Ständer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading